title: Emergent T-helper 2 profile with high interleukin-6 levels correlates with the appearance of bortezomib-induced neuropathic pain.
authors.forename: Silvia
authors.initials: S
authors.lastname: Mangiacavalli
authors.forename: Alessandro
authors.initials: A
authors.lastname: Corso
authors.forename: Mara
authors.initials: M
authors.lastname: De Amici
authors.forename: Marzia
authors.initials: M
authors.lastname: Varettoni
authors.forename: Enrico
authors.initials: E
authors.lastname: Alfonsi
authors.forename: Alessandro
authors.initials: A
authors.lastname: Lozza
authors.forename: Mario
authors.initials: M
authors.lastname: Lazzarino
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy; D009437:Neuralgia / Q000139:chemically induced*; D011446:Prospective Studies; D011719:Pyrazines / Q000009:adverse effects*; D018418:Th2 Cells / Q000187:drug effects*
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D015850:Interleukin-6; D011719:Pyrazines; D000069286:Bortezomib